scispace - formally typeset
Journal ArticleDOI

Randomized trials of myocardial revascularization

Reads0
Chats0
TLDR
In long-term follow-up, surgery does not reduce the occurrence of myocardial infarction or angina compared with medical therapy, and a substantial number of patients do not fit into the criteria adopted for entry into the revascularization trials--a point that is all too frequently forgotten.
About
This article is published in Current Problems in Cardiology.The article was published on 1995-03-01. It has received 16 citations till now. The article focuses on the topics: Revascularization & Atherectomy.

read more

Citations
More filters
Journal ArticleDOI

Race, treatment, and survival among colorectal carcinoma patients in an equal‐access medical system

TL;DR: The aim of this study was to assess the influence of race on the treatment and survival of patients with colorectal carcinoma.
Journal Article

Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting

TL;DR: By decreasing waiting times for CABG, this work may improve patients' quality of life and decrease the psychological morbidity associated with CABGs.
Journal ArticleDOI

Priority points and cardiac events while waiting for coronary bypass surgery

TL;DR: Very long waiting times for CABG are associated with frequent cardiac events, at considerable cost to both patients and health care providers, and priority scores did not predict clinical events while waiting.
References
More filters
Journal ArticleDOI

A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

TL;DR: The clinical and angiographic outcomes were better in patients who received a stent than in those who received standard coronary angioplasty, however, this benefit was achieved at the cost of a significantly higher risk of vascular complications at the access site and a longer hospital stay.
Journal ArticleDOI

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

TL;DR: SK seems to be a safe drug for routine administration in acute myocardial infarction in patients admitted within 12 h after the onset of symptoms and with no contraindications to SK when randomised to receive SK in addition to usual treatment.
Journal ArticleDOI

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

TL;DR: As compared with t-PA therapy for acute myocardial infarction, immediate PTCA reduced the combined occurrence of nonfatal reinfarction or death, was associated with a lower rate of intracranial hemorrhage, and resulted in similar left ventricular systolic function.
Related Papers (5)